SC Ropharma (BSE:RPH) Ending Cash Position: lei19.9 Mil (As of Dec. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSE:RPH SC Ropharma SA BSE:RPH
66 GF Score
Price lei0.21
View Full Analysis

What is SC Ropharma Ending Cash Position?

SC Ropharma BSE:RPH -0.93% 66 Ending Cash Position is lei19.9 Mil as of Dec. 2024. GuruFocus rates BSE:RPH with a GF Score™ of 66/100.

SC Ropharma's Ending Cash Position for the quarter that ended in Dec. 2024 was lei19.9 Mil.

SC Ropharma's quarterly Ending Cash Position increased from Dec. 2023 (lei16.5 Mil) to Jun. 2024 (lei32.5 Mil) but then declined from Jun. 2024 (lei32.5 Mil) to Dec. 2024 (lei19.9 Mil).

SC Ropharma's annual Ending Cash Position increased from Dec. 2022 (lei15.4 Mil) to Dec. 2023 (lei16.5 Mil) and increased from Dec. 2023 (lei16.5 Mil) to Dec. 2024 (lei19.9 Mil).

SC Ropharma Ending Cash Position Related Terms

SC Ropharma Ending Cash Position Historical Data

* Premium members only.

The historical data trend for SC Ropharma's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SC Ropharma Ending Cash Position Chart

SC Ropharma Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.66 10.66 15.42 16.51 19.90

SC Ropharma Semi-Annual Data
Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.42 28.02 16.51 32.48 19.90
BSE:RPH
66GF Score
SC Ropharma SA BSE:RPH
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SC Ropharma Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

SC Ropharma's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=16.513336+3.389069
=19.9

SC Ropharma's Ending Cash Position for the quarter that ended in Dec. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=32.476753+-12.574348
=19.9

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of lei19.9 Mil mean?
SC Ropharma (BSE:RPH) has a Ending Cash Position of lei19.9 Mil as of Dec. 2024. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on SC Ropharma and its competitors.
Is SC Ropharma's Ending Cash Position too high?
SC Ropharma's current Ending Cash Position is lei19.9 Mil. Overall, SC Ropharma has a GF Score™ of 66/100, reflecting its overall financial health beyond just this single metric.
How does SC Ropharma's Ending Cash Position compare to competitors?
SC Ropharma's Ending Cash Position of lei19.9 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Healthcare Providers & Services company?
A good Ending Cash Position depends on the Healthcare Providers & Services industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on SC Ropharma and its competitors. SC Ropharma's current Ending Cash Position is lei19.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SC Ropharma stock overvalued right now?
SC Ropharma (BSE:RPH) has a current Ending Cash Position of lei19.9 Mil. The current Ending Cash Position is lei19.9 Mil. SC Ropharma's overall GF Score™ is 66/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For SC Ropharma (BSE:RPH), the current Ending Cash Position is lei19.9 Mil as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

SC Ropharma Business Description

Address Strada Iuliu Maniu Nr. 55, ETAJ 1, Brasow, ROU, 500091
SC Ropharma SA is engaged in the production, distribution, and Retail sale of pharmaceutical products in specialized stores. Its product portfolio comprises over 50 products in the form of tablets, powders, capsules, and syrups covering 21 therapeutic areas.
66GF Score

Get the complete analysis for BSE:RPH

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

lei0.21
Price